Emmessar Biotech & Nutrition Share Price

Emmessar Biotech & Nutrition Investment Rating

• Master Rating:

• Emmessar Biot.& Nut. has an operating revenue of Rs. 0.36 Cr. on a trailing 12-month basis. An annual revenue de-growth of -73% needs improvement, Pre-tax margin of 255% is great, ROE of 7% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 25 which is a POOR score indicating inconsistency in earnings, a RS Rating of 10 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 149 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of E is the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.